While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Positive results of a colon cancer study conducted ... We take a look at earnings estimates for some clues. The mean of analysts' price targets for Exact Sciences (EXAS) points to a 34.3% upside ...

A positive test means that Cologuard detected blood and gene mutations suggestive of cancer, indicating the need for further investigation with a colonoscopy. A positive result does not mean you have ...

Exact Sciences' management envisions blood-based testing as a viable alternative for those who decline both colonoscopy and Cologuard ... company's recent positive clinical trial results and ...

Edgewood, Ky.-based provider network St. Elizabeth Physicians has added additional drop-off locations for patients prescribed the Cologuard test. The new drop-off points are intended to improve ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

or HCM--a common cause of heart disease in young people--showed positive data. As a result, the company said it has started dosing patients in the second stage of this trial, targeting patients ...

The first overall survival analysis of the KEYNOTE-522 trial showed positive outcomes with neoadjuvant ... and that was a highly significant and meaningful result. We have since had further ...

A long-running race to develop a gene therapy for the most common cause of age-related blindness is heating up. On Wednesday, 4D Molecular Therapeutics announced new data from its program for the ...

The National Examinations Council on Monday released the results of the 2024 SSCE external examination. PUNCH Online confirms that the result is now accessible online. NECO announced the release ...

In a study of more than 3,000 samples, the company reported that its test detected 88.3% of cancers and correctly returned a negative result 90.1% of the time, test features known as sensitivity ...